The FDA has approved a first-of-its-kind treatment for dry age-related macular degeneration (AMD), a leading cause of blindness in adults over 55.
Rates of nearsightedness, or myopia, are skyrocketing in kids—and scientists say it has to do with how little time they’re ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback